Northern Europe vs Peru: Proportion of the target population who received the final dose of
Northern Europe
76.0%
in 2024
Peru
97.0%
in 2024
Northern Europe rank
2nd
Peru rank
3rd
Proportion of the target population who received the final dose of over time
- Northern Europe
- Peru
How they compare
Peru currently reports 97.0% against 76.0% in Northern Europe, a difference of 21.0%.
That makes Peru's figure about 1.3 times Northern Europe's.
The two have swapped places 1 time across 14 shared years of data; in 2011 it was Northern Europe ahead.
Northern Europe ranks 2nd and Peru ranks 3rd of 35 groups.
Northern Europe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Northern Europe | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 72.0% | 40.4% | 31.6% | Northern Europe |
| 2020s | 72.0% | 53.2% | 18.8% | Northern Europe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Northern Europe or Peru?
- Peru, at 97.0% against 76.0% in Northern Europe as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Northern Europe and Peru?
- 21.0%, with Peru ahead.
- How many years of comparable data are there for Northern Europe and Peru?
- 14 years are reported by both, from 2011 to 2024.
- How do Northern Europe and Peru rank globally for proportion of the target population who received the final dose of?
- Northern Europe ranks 2nd and Peru ranks 3rd of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.